| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |